Literature DB >> 23467302

Mechanistic links between COPD and lung cancer.

A McGarry Houghton1.   

Abstract

Numerous epidemiological studies have consistently linked the presence of chronic obstructive pulmonary disease (COPD) to the development of lung cancer, independently of cigarette smoking dosage. The mechanistic explanation for this remains poorly understood. Progress towards uncovering this link has been hampered by the heterogeneous nature of the two disorders: each is characterized by multiple sub-phenotypes of disease. In this Review, I discuss the nature of the link between the two diseases and consider specific mechanisms that operate in both COPD and lung cancer, some of which might represent either chemopreventive or chemotherapeutic targets.

Entities:  

Mesh:

Year:  2013        PMID: 23467302     DOI: 10.1038/nrc3477

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  168 in total

Review 1.  Epidemiology and global impact of chronic obstructive pulmonary disease.

Authors:  David M Mannino
Journal:  Semin Respir Crit Care Med       Date:  2005-04       Impact factor: 3.119

Review 2.  The paradox of pro-inflammatory cytokines in cancer.

Authors:  Charles A Dinarello
Journal:  Cancer Metastasis Rev       Date:  2006-09       Impact factor: 9.264

Review 3.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

4.  Prognostic significance of immunoreactive neutrophil elastase in human breast cancer: long-term follow-up results in 313 patients.

Authors:  Miwa Akizuki; Takashi Fukutomi; Miyuki Takasugi; Satoshi Takahashi; Takashi Sato; Michiko Harao; Takao Mizumoto; Jun-ichi Yamashita
Journal:  Neoplasia       Date:  2007-03       Impact factor: 5.715

5.  Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice.

Authors:  Tirumalai Rangasamy; Chung Y Cho; Rajesh K Thimmulappa; Lijie Zhen; Sorachai S Srisuma; Thomas W Kensler; Masayuki Yamamoto; Irina Petrache; Rubin M Tuder; Shyam Biswal
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

6.  Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo.

Authors:  Mei-Ling Chen; Mikaël J Pittet; Leonid Gorelik; Richard A Flavell; Ralph Weissleder; Harald von Boehmer; Khashayarsha Khazaie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

7.  Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease.

Authors:  Prescott G Woodruff; Michael Wolff; Jens M Hohlfeld; Norbert Krug; Mark T Dransfield; E Rand Sutherland; Gerard J Criner; Victor Kim; Antje Prasse; Michael C Nivens; Kay Tetzlaff; Ralf Heilker; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-12-10       Impact factor: 21.405

8.  Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema.

Authors:  J D'Armiento; S S Dalal; Y Okada; R A Berg; K Chada
Journal:  Cell       Date:  1992-12-11       Impact factor: 41.582

9.  Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

Authors:  Marcin Imielinski; Alice H Berger; Peter S Hammerman; Bryan Hernandez; Trevor J Pugh; Eran Hodis; Jeonghee Cho; James Suh; Marzia Capelletti; Andrey Sivachenko; Carrie Sougnez; Daniel Auclair; Michael S Lawrence; Petar Stojanov; Kristian Cibulskis; Kyusam Choi; Luc de Waal; Tanaz Sharifnia; Angela Brooks; Heidi Greulich; Shantanu Banerji; Thomas Zander; Danila Seidel; Frauke Leenders; Sascha Ansén; Corinna Ludwig; Walburga Engel-Riedel; Erich Stoelben; Jürgen Wolf; Chandra Goparju; Kristin Thompson; Wendy Winckler; David Kwiatkowski; Bruce E Johnson; Pasi A Jänne; Vincent A Miller; William Pao; William D Travis; Harvey I Pass; Stacey B Gabriel; Eric S Lander; Roman K Thomas; Levi A Garraway; Gad Getz; Matthew Meyerson
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

10.  Cathepsin L increases invasion and migration of B16 melanoma.

Authors:  Zhen Yang; James L Cox
Journal:  Cancer Cell Int       Date:  2007-05-08       Impact factor: 5.722

View more
  146 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

Review 2.  Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor.

Authors:  Tzipora Goldkorn; Simone Filosto; Samuel Chung
Journal:  Antioxid Redox Signal       Date:  2014-07-01       Impact factor: 8.401

3.  Function of macrophage scavenger receptor 1 gene polymorphisms in chronic obstructive pulmonary disease with and without lung cancer in China.

Authors:  Liang Xie; Wei Chen; Ran Dong; Bin He; Kaishun Zhao; Li Zhang; Min Zhou; Ping He
Journal:  Oncol Lett       Date:  2018-03-21       Impact factor: 2.967

4.  Smoking-Associated Disordering of the Airway Basal Stem/Progenitor Cell Metabotype.

Authors:  Ruba S Deeb; Matthew S Walters; Yael Strulovici-Barel; Qiuying Chen; Steven S Gross; Ronald G Crystal
Journal:  Am J Respir Cell Mol Biol       Date:  2016-02       Impact factor: 6.914

Review 5.  Mitochondria in chronic obstructive pulmonary disease and lung cancer: where are we now?

Authors:  Hae-Seong Nam; Evgeny Izumchenko; Santanu Dasgupta; Mohammad O Hoque
Journal:  Biomark Med       Date:  2017-06-09       Impact factor: 2.851

6.  Immune phenotypes in lung cancer patients with COPD: potential implications for immunotherapy.

Authors:  Roberto Chalela; Joaquim Gea; Esther Barreiro
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

7.  COPD-dependent effects of genetic variation in key inflammation pathway genes on lung cancer risk.

Authors:  Donovan Watza; Christine M Lusk; Gregory Dyson; Kristen S Purrington; Angela S Wenzlaff; Christine Neslund-Dudas; Ayman O Soubani; Shirish M Gadgeel; Ann G Schwartz
Journal:  Int J Cancer       Date:  2019-12-12       Impact factor: 7.396

Review 8.  Circulating tumor cell interactions with macrophages: implications for biology and treatment.

Authors:  Gerhard Hamilton; Barbara Rath
Journal:  Transl Lung Cancer Res       Date:  2017-08

Review 9.  Lung cancer screening in patients with chronic obstructive pulmonary disease.

Authors:  Jessica Gonzalez; Marta Marín; Pablo Sánchez-Salcedo; Javier J Zulueta
Journal:  Ann Transl Med       Date:  2016-04

Review 10.  Smoking, inflammation and small cell lung cancer: recent developments.

Authors:  Gerhard Hamilton; Barbara Rath
Journal:  Wien Med Wochenschr       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.